Medicamen Organics (NSE:MEDIORG) EPS (Basic): ₹-5.15 (TTM As of Mar. 2026)


NSE:MEDIORG Medicamen Organics Ltd NSE:MEDIORG
21 GF Score
Price ₹25.00
! 11 Warning Signs
View Full Analysis

What is Medicamen Organics EPS (Basic)?

Medicamen Organics NSE:MEDIORG 21 EPS (Basic) is ₹-5.15 as of Mar. 2026. GuruFocus rates NSE:MEDIORG with a GF Score™ of 21/100. The stock has 11 warning signs investors should review.

Medicamen Organics's basic earnings per share (Basic EPS) for the six months ended in Mar. 2026 was ₹-5.15. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-5.15.

Medicamen Organics's EPS (Diluted) for the six months ended in Mar. 2026 was ₹-5.15. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-5.15.

Medicamen Organics's EPS without NRI for the six months ended in Mar. 2026 was ₹-5.15. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -5.15.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Medicamen Organics  (NSE:MEDIORG) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Medicamen Organics EPS (Basic) Related Terms


Medicamen Organics EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Medicamen Organics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicamen Organics EPS (Basic) Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial 0.09 0.83 2.24 3.67 -3.41

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Mar25 Mar26
EPS (Basic) Get a 7-Day Free Trial 0.00 1.10 1.14 2.19 -5.15
NSE:MEDIORG
21GF Score
Medicamen Organics Ltd NSE:MEDIORG
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicamen Organics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Medicamen Organics's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-40.194-0)/11.787
=-3.41

Medicamen Organics's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-60.574-0)/11.762
=-5.15

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-5.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹-5.15 mean?
Medicamen Organics (NSE:MEDIORG) has a EPS (Basic) of ₹-5.15 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medicamen Organics and its competitors.
Is Medicamen Organics' EPS (Basic) too high?
Medicamen Organics' current EPS (Basic) is ₹-5.15. Overall, Medicamen Organics has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Medicamen Organics' EPS (Basic) compare to ZTS?
Medicamen Organics' EPS (Basic) of ₹-5.15 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medicamen Organics and its competitors. Medicamen Organics's current EPS (Basic) is ₹-5.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicamen Organics stock overvalued right now?
Medicamen Organics (NSE:MEDIORG) has a current EPS (Basic) of ₹-5.15. The current EPS (Basic) is ₹-5.15. Medicamen Organics' overall GF Score™ is 21/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Medicamen Organics (NSE:MEDIORG), the current EPS (Basic) is ₹-5.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicamen Organics Business Description

Address Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd develops, manufactures, and distributes a wide range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company operates two WHO Good Manufacturing Practice certified facilities in India, producing products for both domestic and international clients. It provides contract manufacturing and loan license services to various pharmaceutical companies and exports to several countries across Africa, CIS, and South Asia. The principal source of revenue is through the manufacturing, export, and contract services focused on generic and branded pharmaceutical formulations.
21GF Score

Get the complete analysis for NSE:MEDIORG

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.00
Price